Table 4.
Species | Strain(s) | MIC Increase (TRI) | Antibiotic(s) | Pre-Value | Post-Value | Category | Reference |
---|---|---|---|---|---|---|---|
Actinomyces naeslundii | Strain WVU627 | 4.9-fold | Metronidazole Tetracycline |
125 1 5.2 1 |
125 1 7.8 1 |
- - |
[50] |
Enterobacter spp. | 5 biocide-sensitive strains from organic foods | 2-fold–15-fold | Ampicillin Cefotaxime Ceftazidime Sulfamethoxazol |
- - - - |
64 (2) 1 128 (1) 1 64 (2) 1 1024 (2) 1 |
R R R R |
[51] |
Escherichia coli | ATCC 8729 | 391-fold | Metronidazole Tetracycline |
250 1 15.6 1 |
125 1 10.4 1 |
- - |
[50] |
Escherichia coli | NCTC 12900 strain O157 | 16-fold (P1)8192-fold (P2) | Amoxicillin-clavulanic acid Amoxicillin Chloramphenicol Ciprofloxacin Clindamycin Colistin sulfate Erythromycin Fusidic acid Gentamicin Imipenem Rifampicin Tetracycline Trimethoprim Vancomycin |
11 2 13 2 13 2 14 2 0 2 9 2 7 2 0 2 12 2 15 2 5 2 17 2 13 2 0 2 |
0 2 0 2 5 2 14 2 0 2 10 2 0 2 0 2 12 2 11 2 5 2 14 2 0 2 0 2 |
R R R n. a. n. a. n. a. R n. a. n. a. R n. a. R R n. a. |
[10] |
Escherichia coli | ATCC 27325 | 4096-fold | Amoxicillin Amoxicillin-clavulanic acid Chloramphenicol Ciprofloxacin Clindamycin Colistin sulfate Fusidic acid Gentamicin Rifampicin Tetracycline Trimethoprim Vancomycin |
8 1 8 1 16 1 4 1 >256 1 16 1 >256 1 8 1 256 1 32 1 32 1 >256 1 |
8 1 8 1 256 1 4 1 >256 1 16 1 >256 1 8 1 256 1 32 1 32 1 >256 1 |
n. a. n. a. R n. a. n. a. n. a. n. a. n. a. n. a. n. a. n. a. n. a. |
[52] |
Escherichia coli | Strain O55:H7 | 2048-fold | Amoxicillin Amoxicillin-clavulanic acid Chloramphenicol Ciprofloxacin Clindamycin Colistin sulfate Fusidic acid Gentamicin Rifampicin Tetracycline Trimethoprim Vancomycin |
8 1 16 1 16 1 2 1 >256 1 16 1 >256 1 8 1 >256 1 32 1 32 1 0 1 |
8 1 8 1 8 1 2 1 >256 1 16 1 >256 1 16 1 >256 1 32 1 256 1 0 1 |
n. a. n. a. n. a. n. a. n. a. n. a. n. a. n. a. n. a. n. a. R n. a. |
[52] |
Escherichia coli | NCTC 12900 | 8192-fold | Amoxicillin Amoxicillin-clavulanic acid Chloramphenicol Ciprofloxacin Clindamycin Colistin sulfate Fusidic acid Gentamicin Rifampicin Tetracycline Trimethoprim Vancomycin |
32 1 4 1 32 1 2 1 >256 1 8 1 >256 1 16 1 >256 1 32 1 64 1 0 1 |
>256 1 256 1 256 1 2 1 >256 1 16 1 >256 1 16 1 >256 1 >256 1 >256 1 0 1 |
R R R n. a. n. a. n. a. n. a. n. a. n. a. R R n. a. |
[52] |
Fusobacterium nucleatum | ATCC 10953 | None | Metronidazole Tetracycline |
250 1 3.9 1 |
500 1 2.9 1 |
- - |
[50] |
Neisseria subflava | Strain A1078 | None | Metronidazole Tetracycline |
62.5 1 3.9 1 |
52.1 1 6.8 1 |
- - |
[50] |
Pantoea agglomerans | Biocide-sensitive strain from organic foods | 150-fold | Ampicillin Ceftazidime Sulfamethoxazol |
- - - |
64 1 64 1 1024 1 |
R R R |
[51] |
Pantoea ananatis | 2 biocide-sensitive strains from organic foods | 5-fold– 200-fold |
Sulfamethoxazol Trimethoprim-sulfamethoxazol Ampicillin Cefotaxime |
- - - - |
1024 (2) 1 8/152 (2) 1 32 (1) 1 64 (1) 1 |
R R R R |
[51] |
Pantoea spp. | 2 biocide-sensitive strains from organic foods | 2-fold–3-fold | Sulfamethoxazol Ceftazidime Cefotaxime |
- - - |
1024 (1) 1 64 (1) 1 128 (1) 1 |
R R R |
[51] |
Porphyromonas gingivalis | Strain W50 | None | Metronidazole Tetracycline |
31.3 1 3.0 1 |
62.5 1 1.0 1 |
- - |
[50] |
Prevotella nigrescens | Strain T588 | 2-fold | Metronidazole Tetracycline |
62.5 1 1.0 1 |
62.5 1 1.0 1 |
- - |
[50] |
Salmonella spp. | 3 biocide-sensitive strains from organic foods | 2-fold– 200-fold |
Trimethoprim-sulfamethoxazol Cefotaxime Nalidixic acid Ampicillin Sulfamethoxazol Imipenem |
- - - - - - |
8/152 (2) 1 64/128 (2) 1 64 (2) 1 64 (1) 1 1024 (1) 1 32 (1) 1 |
R R R R R R |
[51] |
Salmonella spp. | 6 strains with higher MICs to biocidal products | 500-fold– 10.000-fold (3) |
Piperacillin Ceftiofur Amikacin Gentamicin Kanamycin Chloramphenicol Cefoxitin Nalidixic acid Sulfisoxazole |
<4 3 2 3 4 3 <1 3 <8 3 4 3 16 3 8 3 32 3 |
16 3 >8 3 16 3 4 3 32 3 16 3 32 3 32 3 >256 3 |
I R I I I I R R I |
[16] |
Veillonella dispar | ATCC 17745 | None | Metronidazole Tetracycline |
78.1 1 31.3 1 |
31.3 1 27.4 1 |
- - |
[50] |
1 microdilution method (mg/L); 2 disc diffusion test (mm); 3 NARMS plates (mg/L); “-” = no information; R = resistant; I = intermediate susceptible; S = susceptible; n. a. = not applicable; () = number of strains, isolates or experiments; (P1) = passage 1; (P2) = passage 2.